Article Text

other Versions

Download PDFPDF
Systematic review with meta analysis
Meta-analysis compares anticoagulant strategies in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention
  1. Giuseppe Patti
  1. Campus Bio-Medico University—Cardiovascular Sciences, Rome, Italy
  1. Correspondence to: Dr Giuseppe Patti, Campus Bio-Medico University—Cardiovascular Sciences, Via Alvaro del Portillo, 200, Rome 00128, Italy; g.patti{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Commentary on: Bangalore S, Toklu B, Kotwal A, et al. Anticoagulant therapy during primary percutaneous coronary intervention for acute myocardial infarction: a meta-analysis of randomised trials in the era of stents and P2Y12 inhibitors. BMJ 2014;349:g6419


Optimal anticoagulant therapy in patients receiving primary intervention for acute myocardial infarction (MI) is widely debated. Prior studies have been heterogeneous in doses and concomitant treatments such that it has been unclear whether effects have been those of newer medication or a result of changes in these co-interventions. A meta-analytic approach can allow comparisons between multiple anticoagulant strategies and can help clarify heterogeneity and address power in pooled analyses.


The authors performed a study-level meta-analysis on 22 randomised controlled trials including patients with ST-elevation MI who were undergoing stent placement and were administered P2Y12 …

View Full Text


  • Competing interests None.

  • Provenance and peer review Commissioned; internally peer reviewed.